Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis
Study sponsor: Vanda Pharmaceuticals
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2017-08-04Actual
Enrollment · participants168Actual
Source updated2024-06-13Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.